Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ARNOTT

Showing results (1131-1140 of 1,193) with videos related to

Pageof 120
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2022
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease PatientsJoel Ramirez, Stephanie A Berberian, David P Breen, et al.
Cancer Cell|August 8, 2017
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug ExposureGulfem Dilek Guler, Charles Albert Tindell, Robert Pitti, et al.
Brain Communications|May 12, 2025
White matter tract correlations with spoken language in cerebrovascular diseaseDana N Broberg, Seyyed M H Haddad, Katharine Aveni, et al.
Psychoneuroendocrinology|July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study reportJee Su Suh, Laura M Fiori, Mohammad Ali, et al.
Scientific Reports|March 4, 2025
X-ray microscopy and talbot imaging with the matter in extreme conditions X-ray imager at LCLSEric Galtier, Hae Ja Lee, Dimitri Khaghani, et al.
Journal of Gastroenterology and Hepatology|December 31, 2020
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohortNikolas Plevris, James Fulforth, Spyros Siakavellas, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Frontiers in Neuroscience|October 24, 2022
Retinal nerve fiber layer in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBryan M Wong, Christopher Hudson, Emily Snook, et al.
Nature Communications|May 18, 2022
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillanceRebecca J Rockett, Jenny Draper, Mailie Gall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Pageof 120

Showing results (1131-1140 of 1,193) with videos related to

Sort By:
Pageof 120
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2022
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease PatientsJoel Ramirez, Stephanie A Berberian, David P Breen, et al.
Cancer Cell|August 8, 2017
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug ExposureGulfem Dilek Guler, Charles Albert Tindell, Robert Pitti, et al.
Brain Communications|May 12, 2025
White matter tract correlations with spoken language in cerebrovascular diseaseDana N Broberg, Seyyed M H Haddad, Katharine Aveni, et al.
Psychoneuroendocrinology|July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study reportJee Su Suh, Laura M Fiori, Mohammad Ali, et al.
Scientific Reports|March 4, 2025
X-ray microscopy and talbot imaging with the matter in extreme conditions X-ray imager at LCLSEric Galtier, Hae Ja Lee, Dimitri Khaghani, et al.
Journal of Gastroenterology and Hepatology|December 31, 2020
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohortNikolas Plevris, James Fulforth, Spyros Siakavellas, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Frontiers in Neuroscience|October 24, 2022
Retinal nerve fiber layer in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBryan M Wong, Christopher Hudson, Emily Snook, et al.
Nature Communications|May 18, 2022
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillanceRebecca J Rockett, Jenny Draper, Mailie Gall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Pageof 120